Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Polaris Picks Immuneering, Developer of Personalized Cancer Test, as First Life Sciences Startup in Dog Patch Incubator
|
Luke Timmerman |
10/08/09 |
Boston
|
|
$10M for Tetraphase
|
Wade Roush |
09/25/09 |
Boston
|
|
Genzyme Says Supplies, Sales of Two Enzyme Drugs Will Be Even Lower Than Previously Predicted
|
Wade Roush |
09/23/09 |
Boston
|
|
Vitality, Connecting Pill Bottles to the Internet, Nudges People to Remember Their Meds
|
Wade Roush |
08/13/09 |
Boston
|
|
5AM Ventures Beats Goal for 3rd Fund
|
Roxanne Palmer |
07/07/09 |
Boston
|
|
Biogen Gets Int’l Rights to Acorda’s MS Drug
|
Roxanne Palmer |
07/01/09 |
Boston
|
|
Life Science Leaders Converge in Newport, PubGet Gets Your Paper Faster, I-Therapeutix Eyes $15M Prize & More Boston-Area Life Sciences News
|
Roxanne Palmer |
06/24/09 |
Boston
|
|
Three Local Biotechs Raising Cash
|
Juha-Pekka Tikka |
06/04/09 |
San Diego
|
|
Proteon Adds $12M To B Round
|
Roxanne Palmer |
05/28/09 |
Boston
|
|
Oracle Forges Plan To Acquire Virtual Iron, MA Gets $25M For Wind Turbine Testing Facility, NBC’s Peacock Equity Fund Crows Over EveryZing, & More Boston-Area Deals News
|
Roxanne Palmer |
05/15/09 |
Boston
|
|
Sepracor Asks FDA to Okay Epilepsy Drug
|
Wade Roush |
03/31/09 |
Boston
|
|
Seahorse Buys BioProcessors, Raises $6M
|
Wade Roush |
03/10/09 |
Boston
|
|
Impinj Navigates Nascent RFID Market with Unique Technology, Strategy—and Patience
|
Gregory T. Huang |
02/24/09 |
Seattle
|
|
Charles River Cutting 3% of Workers
|
Ryan McBride |
02/10/09 |
Boston
|
|
NitroMed Delays Vote on Drug Sale
|
Ryan McBride |
01/14/09 |
Boston
|
|
Targanta Cuts 75 Percent of Staff
|
Wade Roush |
12/18/08 |
Boston
|
|
Cell Therapeutics, Spectrum Form Joint Venture
|
Gregory T. Huang |
11/26/08 |
Seattle
|
|
Layoffs at Mascoma, Javelin
|
Wade Roush |
11/14/08 |
Boston
|
|
Puget Sound Energy Buys Wind Turbines, Voyager Backs Video Ads, 10 Reasons Why Startups Fail, & More Seattle-Area Deals News
|
Gregory T. Huang |
11/12/08 |
Seattle
|
|
Torrey Pines Therapeutics Sells Alzheimer’s Program to Partner
|
Bruce V. Bigelow |
11/10/08 |
San Diego
|
|
Epix Cutting 23 Percent of Workers
|
Ryan McBride |
10/23/08 |
Boston
|
|
Archemix Looks to Hitch Eli Lilly to Aptamer Express in New Deal
|
Ryan McBride |
10/20/08 |
Boston
|
|
Charles River Opens Pre-Clinical Labs in Shanghai
|
Ryan McBride |
10/15/08 |
Boston
|
|
New Pfizer Incubator Chief Looks Far and Wide for New Science, But Backs Off Plans for Boston Site
|
Ryan McBride |
10/14/08 |
San Diego
|
|
The Boston-Area Obesity Treatment Cluster: Are Flood Gates Opening for Weight-Loss Drugs and Devices?
|
Ryan McBride |
10/08/08 |
Boston
|
|
Idera Drug Falls Short in Phase 2
|
Ryan McBride |
10/01/08 |
Boston
|
|
Indevus Puts New Acromegaly Treatment Head-to-Head with Novartis Treatment in Phase 3 Trial
|
Ryan McBride |
09/30/08 |
Boston
|
|
Sirtris’ Westphal Enjoying Life Under GSK Ownership; Hints at Positive Human Data on Next-Gen Drugs to Extend Healthy Life (and Still Partying on Fridays)
|
Ryan McBride |
09/18/08 |
Boston
|
|
Sirtris Gains SIRT3 Licenses from Harvard
|
Ryan McBride |
09/16/08 |
Boston
|
|
Phase Forward Buys Clarix
|
Wade Roush |
09/05/08 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
